UltraOral Ltd

UltraOral Ltd is an Israeli biotechnology research company founded in 2023 that specializes in advanced drug and nutraceutical delivery systems. The company has developed a patent-protected, thermo-active chewing gum platform designed to self-warm during the chewing process. By engineering this precise, reproducible thermal environment within the mouth, the technology is intended to significantly enhance the absorption of pharmaceutical and nutraceutical active ingredients directly through intraoral tissue into the bloodstream. This method is engineered to bypass the gastrointestinal tract and liver, thereby avoiding the degradation and slower onset of action typically associated with swallowing traditional pills, capsules, or liquids.

The company's technology is intended to be a licensable platform across 13 or more verticals, including periodontal health, cognitive performance, pain management, and weight loss. By focusing on non-invasive, efficient delivery solutions, UltraOral aims to provide consumers with improved health outcomes and enhanced quality of life. The platform is supported by intellectual property, including patent applications for its thermal energy systems for administering active agents. The organization, headquartered in Ra'anana, Israel, operates with a focus on biotechnology innovation to transform how consumers receive nutritional supplements and API delivery solutions.